Literature DB >> 9413512

Borna disease virus is not sensitive to amantadine.

W Hallensleben1, M Zocher, P Staeheli.   

Abstract

Successful inhibition of Borna disease virus (BDV) by amantadine in cultured cells and in an infected human individual has been reported [Bode et al. (1997) Lancet 349: 178-179]. We now found that infection of monkey Vero cells by laboratory strains of BDV was not influenced by amantadine under conditions that reduced the yields of influenza A virus by about 400 fold. Amantadine treatment of Vero cells persistently infected with BDV did not result in reduced viral RNA levels, and application of the drug to persistently infected BALB/c mice had no effect on the concentration of BDV in their brains. Thus, susceptibility to amantadine is not a characteristic of BDV, although it may be observed with certain primary virus isolates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413512     DOI: 10.1007/s007050050221

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

Review 1.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology.

Authors:  W Hallensleben; M Schwemmle; J Hausmann; L Stitz; B Volk; A Pagenstecher; P Staeheli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.

Authors:  O Planz; S Pleschka; S Ludwig
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Mechanism of the antiviral action of 1-beta-D-arabinofuranosylcytosine on Borna disease virus.

Authors:  Romain Volmer; Jeffrey J Bajramovic; Urs Schneider; Sandra Ufano; Sylvie Pochet; Daniel Gonzalez-Dunia
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Inhibition of Borna disease virus replication by ribavirin.

Authors:  I Jordan; T Briese; D R Averett; W I Lipkin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 6.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

7.  2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread.

Authors:  Jeffrey J Bajramovic; Romain Volmer; Sylvie Syan; Sylvie Pochet; Daniel Gonzalez-Dunia
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.

Authors:  Marylou V Solbrig; Robert Schlaberg; Thomas Briese; Nigel Horscroft; W Ian Lipkin
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread.

Authors:  Jeffrey J Bajramovic; Sylvie Syan; Michel Brahic; Juan Carlos de la Torre; Daniel Gonzalez-Dunia
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  Mechanism of Borna disease virus entry into cells.

Authors:  D Gonzalez-Dunia; B Cubitt; J C de la Torre
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.